医学
肺炎球菌结合疫苗
菌血症
入射(几何)
肺炎链球菌
血培养
儿科
置信区间
肺炎球菌感染
累积发病率
回顾性队列研究
急诊科
队列
内科学
免疫学
抗生素
微生物学
生物
精神科
光学
物理
作者
Matthew L. Stoll,Lorry G. Rubin
出处
期刊:Archives of pediatrics & adolescent medicine
[American Medical Association]
日期:2004-07-01
卷期号:158 (7): 671-671
被引量:134
标识
DOI:10.1001/archpedi.158.7.671
摘要
Background
The optimal diagnostic approach to and management of well-appearing, highly febrile young children has been a matter of debate owing to the possibility of clinically inapparent, or occult, bacteremia (OB). The most common causative organism of OB isStreptococcus pneumoniae.Universal immunization with a heptavalent pneumococcal conjugate vaccine (PCV7) has recently been implemented, but there are limited data on the impact of this vaccine on the incidence of OB. Objective
To evaluate the incidence of OB in the era of routine use of PCV7. Methods
We conducted a retrospective cohort study of highly febrile (temperature, 39°C) children between the ages of 2 months and 36 months who had blood cultures performed in the emergency department or urgent care center between December 11, 2001, and March 5, 2003, and were discharged to home at the time of the initial visit. Results
Of 329 blood cultures obtained from children who met inclusion criteria and did not meet exclusion criteria, 3 (0.91%; 95% confidence interval, 0%-1.9%) yielded a pathogenic bacterium; all wereS pneumoniae.Neither an elevated total white blood cell count, an elevated absolute neutrophil count, nor an increased percentage of bands was highly predictive of OB. Blood cultures positive for organisms were more commonly due to contaminants (4; 95% confidence interval, 0%-2.4%) than pathogens. Conclusions
In the PCV7 era, OB is uncommon in highly febrile children 2 to 36 months of age. With continued use of PCV7, the routine practice of obtaining blood cultures and complete blood cell counts may no longer be indicated in previously healthy, well-appearing, highly febrile children 2 to 36 months of age, particularly those who have received at least 1 dose of PCV7.
科研通智能强力驱动
Strongly Powered by AbleSci AI